SenesTech, Inc. (SNES)
0.829
-0.01
(-0.71%)
USD |
NASDAQ |
Oct 06, 16:00
0.83
0.00 (0.00%)
Pre-Market: 20:00
SenesTech Net Income (Quarterly) : -1.832M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.832M |
| March 31, 2026 | -2.063M |
| December 31, 2025 | -1.804M |
| September 30, 2025 | -1.298M |
| June 30, 2025 | -1.616M |
| March 31, 2025 | -1.665M |
| December 31, 2024 | -1.255M |
| September 30, 2024 | -1.513M |
| June 30, 2024 | -1.584M |
| March 31, 2024 | -1.832M |
| December 31, 2023 | -1.733M |
| September 30, 2023 | -1.947M |
| June 30, 2023 | -1.993M |
| March 31, 2023 | -2.037M |
| December 31, 2022 | -2.148M |
| September 30, 2022 | -2.646M |
| June 30, 2022 | -2.569M |
| March 31, 2022 | -2.332M |
| December 31, 2021 | -2.494M |
| Date | Value |
|---|---|
| September 30, 2021 | -2.253M |
| June 30, 2021 | -1.70M |
| March 31, 2021 | -1.821M |
| December 31, 2020 | -2.072M |
| September 30, 2020 | -1.919M |
| June 30, 2020 | -1.629M |
| March 31, 2020 | -2.731M |
| December 31, 2019 | -2.78M |
| September 30, 2019 | -2.585M |
| June 30, 2019 | -2.289M |
| March 31, 2019 | -2.364M |
| December 31, 2018 | -2.63M |
| September 30, 2018 | -2.833M |
| June 30, 2018 | -4.113M |
| March 31, 2018 | -2.665M |
| December 31, 2017 | -2.311M |
| September 30, 2017 | -2.937M |
| June 30, 2017 | -3.583M |
| March 31, 2017 | -3.455M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Enveric Biosciences, Inc. | -3.028M |
| LENZ Therapeutics, Inc. | -31.92M |
| Impact BioMedical, Inc. | -0.70M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.77M |
| Total Expenses (Quarterly) | 2.602M |
| EPS Diluted (Quarterly) | -0.3454 |
| Enterprise Value | 1.896M |
| Gross Profit Margin (Quarterly) | 69.74% |
| Profit Margin (Quarterly) | -237.9% |
| Earnings Yield | -164.1% |
| Normalized Earnings Yield | -164.15 |